Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serkan Demir

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Multiple Sclerosis and Related Disorders|May 17, 2021
A comprehensive assessment of patient experience and disease-related awareness in multiple sclerosis: A questionnaire-based nation-wide survey in TurkeySerkan Demir, Melih Tutuncu, Cihat Uzunkopru, et al.
Neurology India|May 9, 2022
Reconsidering the Relationship Between Hand Preference and Cerebral Vascular Dominance: A Computed Tomography (CT) Angiography StudyNazlı Gamze Bulbul, Serkan Demir, Suat Özkan, et al.
European Neurology|August 3, 2021
The Impact of the COVID-19 Lockdown on the Quality of Life in Chronic Neurological Diseases: The Results of a COVQoL-CND StudySevki Sahin, Sibel Karsidag, Nilgun Cinar, et al.
Multiple Sclerosis and Related Disorders|May 29, 2023
mRNA versus inactivated virus COVID-19 vaccines in multiple sclerosis: Humoral responses and protectivity-Does it matter?Melih Tütüncü, Serkan Demir, Gökhan Arslan, et al.
Noro Psikiyatri Arsivi|August 30, 2023
The Effect of Smoking on Inactivated and mRNA Vaccine Responses Applied to Prevent COVİD-19 in Multiple SclerosisSedat Şen, Gökhan Arslan, Melih Tütüncü, et al.
Multiple Sclerosis and Related Disorders|February 26, 2022
The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course?Sedat Sen, Asli Tuncer, Serkan Ozakbas, et al.
Journal of Neuroimmunology|July 22, 2025
Comparative efficacy of rituximab versus azathioprine in the treatment of MOG antibody-associated disease (MOGAD)Sedat Şen, Murat Kürtüncü, Serkan Demir, et al.
Scientific Reports|April 5, 2025
Exome sequencing reveals low-frequency and rare variant contributions to multiple sclerosis susceptibility in Turkish familiesFurkan Büyükgöl, Berk Gürdamar, Mehmet Ufuk Aluçlu, et al.
Journal of Neurology|January 8, 2026
Real-world effectiveness and safety of eculizumab in AQP4-IgG-positive neuromyelitis optica spectrum disorderEmine Rabia Koc, Mehmet Fatih Yetkin, Furkan Saridas, et al.
Balkan Medical Journal|June 3, 2024
Clinical, Demographic, and Radiological Characteristics of Patients Demonstrating Antibodies Against Myelin Oligodendrocyte GlycoproteinSümeyye Koç, Sedat Şen, Yüksel Terzi, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Multiple Sclerosis and Related Disorders|May 17, 2021
A comprehensive assessment of patient experience and disease-related awareness in multiple sclerosis: A questionnaire-based nation-wide survey in TurkeySerkan Demir, Melih Tutuncu, Cihat Uzunkopru, et al.
Neurology India|May 9, 2022
Reconsidering the Relationship Between Hand Preference and Cerebral Vascular Dominance: A Computed Tomography (CT) Angiography StudyNazlı Gamze Bulbul, Serkan Demir, Suat Özkan, et al.
European Neurology|August 3, 2021
The Impact of the COVID-19 Lockdown on the Quality of Life in Chronic Neurological Diseases: The Results of a COVQoL-CND StudySevki Sahin, Sibel Karsidag, Nilgun Cinar, et al.
Multiple Sclerosis and Related Disorders|May 29, 2023
mRNA versus inactivated virus COVID-19 vaccines in multiple sclerosis: Humoral responses and protectivity-Does it matter?Melih Tütüncü, Serkan Demir, Gökhan Arslan, et al.
Noro Psikiyatri Arsivi|August 30, 2023
The Effect of Smoking on Inactivated and mRNA Vaccine Responses Applied to Prevent COVİD-19 in Multiple SclerosisSedat Şen, Gökhan Arslan, Melih Tütüncü, et al.
Multiple Sclerosis and Related Disorders|February 26, 2022
The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course?Sedat Sen, Asli Tuncer, Serkan Ozakbas, et al.
Journal of Neuroimmunology|July 22, 2025
Comparative efficacy of rituximab versus azathioprine in the treatment of MOG antibody-associated disease (MOGAD)Sedat Şen, Murat Kürtüncü, Serkan Demir, et al.
Scientific Reports|April 5, 2025
Exome sequencing reveals low-frequency and rare variant contributions to multiple sclerosis susceptibility in Turkish familiesFurkan Büyükgöl, Berk Gürdamar, Mehmet Ufuk Aluçlu, et al.
Journal of Neurology|January 8, 2026
Real-world effectiveness and safety of eculizumab in AQP4-IgG-positive neuromyelitis optica spectrum disorderEmine Rabia Koc, Mehmet Fatih Yetkin, Furkan Saridas, et al.
Balkan Medical Journal|June 3, 2024
Clinical, Demographic, and Radiological Characteristics of Patients Demonstrating Antibodies Against Myelin Oligodendrocyte GlycoproteinSümeyye Koç, Sedat Şen, Yüksel Terzi, et al.
Pageof 8